SHR-1916: A Novel PEGylated Interleukin-2 Analogue with Altered Cellular Selectivity and Improved Pharmacokinetic Profiles for Cancer Immunotherapy

Xianglin Kong,1,2 Yuan Lin,2 Chao Ouyang,2 Hao Chen,2 Xiangdong Gao1 1Jiangsu Key Laboratory of Druggability of Biopharmaceuticals and State Key Laboratory of Natural Medicines, School of Life Science and Technology, China Pharmaceutical University, Nanjing, 210009, People’s Republic of China; 2Jian...

Повний опис

Бібліографічні деталі

Автори:	Kong X, Lin Y, Ouyang C, Chen H, Gao X
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Dove Medical Press 2025-02-01
Серія:	Drug Design, Development and Therapy
Предмети:	interleukin-2 mutein long-acting receptor-binding bias antitumor effect
Онлайн доступ:	https://www.dovepress.com/shr-1916-a-novel-pegylated-interleukin-2-analogue-with-altered-cellula-peer-reviewed-fulltext-article-DDDT
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!